Malignant melanoma (metastatic)

Por Larkin, James, Gore, Martin
Publicado em 2008

Renal Cell Cancer: What Can We Learn from Pre-Operative Studies?

Por Fisher, Rosalie, Larkin, James
Publicado em 2011

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

Por Fisher, Rosalie, Larkin, James
Publicado em 2012

Individualising treatment choices in a crowded treatment algorithm

Por Fisher, Rosalie, Larkin, James
Publicado em 2013

Renal cell carcinoma and the use of sorafenib

Por Larkin, James MG, Eisen, Tim
Publicado em 2006

Malignant melanoma (metastatic)

Por Fisher, Rosalie Anne, Larkin, James
Publicado em 2010

Adrenal insufficiency and checkpoint inhibitors for cancer

Por Morganstein, Daniel L, Larkin, James
Publicado no Clin Med (Lond) (2020)

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib

Por Vasudev, Naveen S., Larkin, James M.G.
Publicado em 2011

Inter and Intratumour Heterogeneity: A Barrier to Individualized Medical Therapy in Renal Cell Carcinoma?

Por Fisher, Rosalie, Larkin, James, Swanton, Charles
Publicado em 2012

Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity

Por Fisher, Rosalie, Larkin, James, Swanton, Charles
Publicado em 2011

Experience with sunitinib in the treatment of metastatic renal cell carcinoma

Por Schmidinger, Manuela, Larkin, James, Ravaud, Alain
Publicado em 2012

Renal cell carcinoma. Translational biology, personalized medicine and novel therapeutic targets

Por Vasudev, Naveen S, Larkin, James M G
Publicado em 2013

New survival standards for advanced melanoma

Por Spain, Lavinia, Larkin, James, Turajlic, Samra
Publicado no Br J Cancer (2020)

Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm

Por Khattak, Muhammad, Fisher, Rosalie, Turajlic, Samra, Larkin, James
Publicado em 2013

Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection

Por Flynn, Michael, Pickering, Lisa, Larkin, James, Turajlic, Samra
Publicado no Ther Adv Med Oncol (2018)

Future career intentions of recent GP graduates in Ireland: a trend analysis study

Por Pericin, Ivana, Mansfield, Gerard, Larkin, James, Collins, Claire
Publicado no BJGP Open (2018)

What is the risk of intracranial bleeding during anti-VEGF therapy?

Por Carden, Craig P., Larkin, James M.G., Rosenthal, Mark A.
Publicado em 2008

Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies

Por Larkin, James M.G., Pyle, Lynda M., Gore, Martin E.
Publicado em 2010

Translational Implications of Tumor Heterogeneity

Por Jamal-Hanjani, Mariam, Quezada, Sergio A., Larkin, James, Swanton, Charles
Publicado no Clin Cancer Res (2015)

The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK

Por Larkin, James, Hatswell, Anthony J., Nathan, Paul, Lebmeier, Maximilian, Lee, Dawn
Publicado no PLoS One (2015)